Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Nabeshima, T

    1. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice.
      K Yamada, Y Noda, T Hasegawa, Y Komori, T Nikai, H Sugihara and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 460-466;

  2. Nakahata, N

    1. Homologous desensitization of thromboxane A2 receptor in 1321N1 human astrocytoma cells.
      K Sakai, N Nakahata, H Ono, T Yamamoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 829-836;

  3. Nakano, H

    1. Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
      H Imamura, Y Furukawa, H Nakano, M Kasama, Y Hoyano and S Chiba
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 467-472;

  4. Nakano, T

    1. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
      Y Abe, R Ishisu, K Onishi, K Sekioka, A Narimatsu and T Nakano
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 433-439;

  5. Nalwalk, J W

    1. Characterization of the antinociceptive properties of cimetidine and a structural analog.
      B Y Li, J W Nalwalk, L A Barker, P Cumming, M E Parsons and L B Hough
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 500-508;

  6. Nambi, P

    1. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
      E H Ohlstein, P Nambi, A Lago, D W Hay, G Beck, K L Fong, E P Eddy, P Smith, H Ellens and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 609-615;

  7. Narimatsu, A

    1. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
      Y Abe, R Ishisu, K Onishi, K Sekioka, A Narimatsu and T Nakano
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 433-439;

  8. Negretti, A

    1. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
      C Zocchi, E Ongini, A Conti, A Monopoli, A Negretti, P G Baraldi and S Dionisotti
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 398-404;

  9. Nelson, D L

    1. Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.
      D B Wainscott, V L Lucaites, J D Kursar, M Baez and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 720-727;

  10. Nikai, T

    1. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice.
      K Yamada, Y Noda, T Hasegawa, Y Komori, T Nikai, H Sugihara and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 460-466;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement